Preclinical model systems are invaluable tools for drug discovery and development. But many complex diseases, such as nonalcoholic steatohepatitis (NASH), are difficult to recapitulate in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback